Patients with SMZL showed a nonsignificant trend toward worse OS (HR=1.50; 95% CI: 0.51-4.44).
← all excerpts
Comparative effectiveness of immunotherapy alone or with chemotherapy as first-line treatment for marginal zone lymphoma.
1
—
—
Patients with SMZL showed a nonsignificant trend toward worse OS (HR=1.50; 95% CI: 0.51-4.44).